Study at a glance
How do hormones control vitamin D activation and breakdown?
This page explains how hormone signals control both the activation and breakdown of vitamin D. Researchers studied the parts of DNA that control these processes and removed selected control regions or enzymes to test their roles. Most of these experiments used laboratory models rather than people.
Did the kidneys and intestine control vitamin D in the same way?
Active vitamin D increases production of CYP24A1, an enzyme that helps break it down. This allows the active hormone to limit its own effects. In the kidney, parathyroid hormone usually increases vitamin D activation and reduces breakdown. Another hormone, FGF23, usually shifts the balance in the opposite direction. The studies also showed that control differs between tissues. The kidney helps control vitamin D throughout the body, while the intestine can control vitamin D activity within its own tissue.
Can these vitamin D control findings be applied to people?
The response to FGF23 depends on the amount given, timing and tissue being studied. The rules seen in the kidney do not apply in exactly the same way everywhere else. Changes within the intestine need not produce the same blood changes as changes in the kidney. These findings explain how activation and breakdown work together, but they do not show that people will have effects of the same size as those seen in laboratory models.
Read the full article below ↓What question does this evidence answer?
Vitamin D clearance changes in response to endocrine signals and tissue context. The central question is how CYP24A1 is regulated relative to CYP27B1, the activation enzyme, and how that balance controls active vitamin D availability within the wider vitamin D enzyme pathways.
What did the researchers find?
Calcitriol stimulates CYP24A1 through VDR/RXR-responsive regulatory regions, forming direct negative feedback. In the kidney, PTH generally suppresses Cyp24a1 while increasing Cyp27b1, whereas FGF23 usually drives the system in the opposite direction.
Genomic and enhancer-deletion studies show that kidney and nonrenal tissues do not use identical regulatory architecture. Tissue-specific deletion experiments also separate systemic renal control from local intestinal CYP24A1 activity.
Why does this matter?
Activation and degradation are regulated together. A rise in active-hormone signalling can induce its own catabolic machinery, while PTH and FGF23 shift the renal balance according to mineral-homeostatic needs. Clearance therefore helps determine both how much active vitamin D is available and how long the signal persists, which is one reason Vitamin D Thresholds vs Targets requires physiological context rather than a single isolated number.
What are the important qualifications?
- FGF23 responses are not unconditional; dose, timing and tissue context matter.
- Renal regulation should not be projected unchanged onto every nonrenal tissue.
- Local intestinal CYP24A1 activity can matter without producing the same systemic effect as renal CYP24A1.
- Most causal regulatory experiments are in model systems, so quantitative human equivalence should not be assumed.
Primary evidence and publication details
Meyer MB, Lee SM, Carlson AH, et al. A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues. J Biol Chem. 2019;294:14467-14481.
Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. J Biol Chem. 2010;285:15599-15610.
Yoon SH, Meyer MB, Arevalo C, et al. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J Clin Invest. 2023;133:e163627.
Fuchs MAA, Grabner A, Shi M, et al. Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. J Clin Invest. 2025;135:e179882.
Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. 2018.
Related reading
A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study
A total of 4080 participants were recruited.
Original paper ↗Read more →Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
Hypercalcemic hyperparathyroidism has been associated with poor outcomes after kidney transplantation (KTx).
Original paper ↗Read more →Gender specific association of parathyroid hormone and vitamin D with metabolic syndrome in population with preserved renal function
The association of parathyroid hormone (PTH) and vitamin D with Metabolic syndrome (MetS) was evaluated using representative data from the Korean population.
Original paper ↗Read more →Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients?
We aimed to study the effect of PTH at the time of transplantation on risk of post-transplant vascular events in renal transplant recipients with and without pre-transplant PTX.
Original paper ↗Read more →Misdiagnosis of chronic kidney disease and parathyroid hormone testing during the past 16 years
Chronic kidney disease (CKD) is a prevalent pathological condition worldwide.
Original paper ↗Read more →Prognosis comparison in chronic kidney disease stages 4 to 5 patients with low parathyroid hormone level due to different causes
This study examines prognostic implications of PTH reduction from different etiologies.
Original paper ↗Read more →Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients
To date, data simultaneously evaluating these parameters and interwoven relations on renal outcomes are scarce.
Original paper ↗Read more →Tubular functional capacity and maladaptive parathyroid hormone response in early-stage chronic kidney disease
TFC was evaluated by measuring effective renal plasma flow (mERPF, mL/min/1.73m2) using (131I) Hippurate (131I-H) clearance, while GFR was measured using (99m) Tc-DTPA (mGFR, mL/min/1.73m2).
Original paper ↗Read more →Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
The purpose of this review is to highlight our current understanding of the molecular mechanisms underlying the interaction between vitamin D, FGF23, PTH, and RAAS, and to discuss the role of these mechanisms in physiology and pathophysiology.
Original paper ↗Read more →Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease
In this cross-sectional study, we evaluated the correlations of intact FGF23, c-terminal FGF23, and the FGF23 ratio (c-terminal to intact) with some inflammatory cytokines in 111 elderly patients with advanced CKD not yet in dialysis.
Original paper ↗Read more →Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule
Fibroblast growth factor 23 (FGF23) is a potent regulator of phosphate (Pi) and vitamin D homeostasis.
Original paper ↗Read more →Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
The objective of this study is to evaluate the effect of oral sodium bicarbonate on circulating FGF23 levels in patients with CKD.
Original paper ↗Read more →Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
The hormone fibroblast growth factor 23 (FGF23) is secreted from bone and is involved in phosphorus (P) metabolism.
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
We aimed to examine associations among serum 25-hydroxyvitamin D (25OHD) levels, 1,25-dihyroxyvitamin D (1,25OHD) levels, vitamin D receptor (VDR) polymorphisms, and renal function based on estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes.
Original paper ↗Read more →Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Original paper ↗Read more →Low-dose oral cholecalciferol is associated with higher numbers of Helios+ and total Tregs than oral calcitriol in renal allograft recipients: an observational study
We evaluated whether there was a difference in the absolute numbers of Helios+, Helios−, CTLA-4+, IFNg+, and total Tregs among the patient groups.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →Renal and Intestinal CYP24A1 Regulation: Study Summary
Study summary of Fuchs and colleagues examining how renal and intestinal CYP24A1 have distinct roles in systemic and local vitamin D clearance.
Read more →Original sources
A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues
Published in J Biol Chem (2019).
Publication details
Meyer MB, Lee SM, Carlson AH, et al. A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues. J Biol Chem. 2019;294:14467-14481.
A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3
Published in J Biol Chem (2010).
Publication details
Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. J Biol Chem. 2010;285:15599-15610.
A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Publication details
Yoon SH, Meyer MB, Arevalo C, et al. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J Clin Invest. 2023;133:e163627.
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Publication details
Fuchs MAA, Grabner A, Shi M, et al. Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. J Clin Invest. 2025;135:e179882.
Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3
Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3.
Publication details
Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. 2018.